CYP3A5 genotyping for assessing the efficacy of treatment with simvastatin and atorvastatin

In this work, we examined the impact of polymorphism in the cytochrome P450 (CYP) 3A5 gene, CYP3A5*1 (6986A > G, rs 776746), on the reduction in the lipid levels caused by simvastatin and atorvastatin. We studied 350 hyperlipidemic patients who received 10-40 mg of atorvastatin (n = 175) or simva...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolovou, Genovefa, Kolovou, Vana, Ragia, Georgia, Mihas, Constantinos, Diakoumakou, Olga, Vasiliadis, Ioannis, Mavrogeni, Sophie, Vartela, Vassiliki, Manolopoulos, Vangelis G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Genética 2015
Materias:
Human and Medical Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530653/
https://www.ncbi.nlm.nih.gov/pubmed/26273214
http://dx.doi.org/10.1590/S1415-4757382220140239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530653/
https://www.ncbi.nlm.nih.gov/pubmed/26273214
http://dx.doi.org/10.1590/S1415-4757382220140239

Ejemplares similares